Please see below to view the coverage details for this session entry.

Thursday, October 25


Manufacturing Capabilities in Texas

The manufacturing process for biologics and small molecules can be highly complex.  Emerging technologies are attempting to reduce this complexity and its associated cost.  Texas has made a giant leap forward in its manufacturing capabilities.  Join us for a discussion on some of the current manufacturing capabilities within Texas. 

Thursday October 25, 2012 1:00pm - 1:45am
Ballroom A (9721 Arboretum Boulevard, Austin, TX 78759)

Rahul Singhvi, ScD, MBA

Managing Director, Caliber Biotherapeutics

Andrew Strong

President and Chief Executive Officer, Kalon Biotherapeutics, LLC

David Smith

Head of Lonza Bioscience Cell Therapy, Lonza, Inc

Curt Bilby, PhD (Moderator)

President and Chief Executive Officer, Terapio